ArticleAngiogenesis2026
An Rnf213-deficient hypoperfusion model reveals Moyamoya-relevant neurovascular remodeling.
Article in Angiogenesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Moyamoya disease (MMD) is a chronic cerebrovascular disorder characterized by progressive stenosis of the terminal portions of the bilateral internal carotid arteries and their major branches, accompanied by the development of an abnormal vascular network at the base of the brain. Although RNF213 is the major susceptibility gene, its relatively low penetrance in MMD suggests that genetic predisposition requires synergistic interaction with environmental stressors to induce the characteristic pathological vascular remodeling. Studies have demonstrated that patients with MMD exhibit mild stenosis of the common carotid artery (CCA) diameter. Furthermore, a reduction in CCA diameter is associated with an increase in cerebral blood volume and a prolongation of mean transit time. Based on this novel clinical finding, we established a mouse model combining Rnf213 knockout with bilateral common carotid artery stenosis. These mice exhibited hypoperfusion-induced neurovascular remodeling with moyamoya-relevant features, including cerebral hemorrhage, infarction, and extensive proliferation of fragile microvessels. Mechanistically, RNF213 knockdown sensitizes cerebral vessels to hypoperfusion stress and promotes the proliferation and migration of brain microvascular endothelial cells in the absence of shear stress. In conclusion, these results link Rnf213 deficiency with mild CCA stenosis under hypoperfusion stress, providing additional insights into the complex systemic manifestations of MMD pathogenesis.
Indexed as
Identifiers
42265374What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.